Amarin to Present at 38th Annual J.P. Morgan Healthcare Conference
January 06 2020 - 6:00AM
Amarin Corporation plc (NASDAQ:AMRN) announced today that John F.
Thero, Amarin's president and chief executive officer, is scheduled
to present at the 38th Annual J.P. Morgan Healthcare Conference in
San Francisco, CA on Wednesday, January 15, 2020 at 10:30 a.m.
Pacific Time / 1:30 p.m. Eastern Time.
A live audio webcast of the presentation will be
available at: http://www.amarincorp.com and will be accessible at
the same link for 30 days.
About Amarin
Amarin Corporation plc is a rapidly growing,
innovative pharmaceutical company focused on developing and
commercializing therapeutics to cost-effectively improve
cardiovascular health. Amarin’s lead product, VASCEPA® (icosapent
ethyl), is available by prescription in the United States, Lebanon
and the United Arab Emirates, and is expected to be available in
Canada through an anticipated February 2020 commercial launch.
Amarin, together with its commercial partners in select
geographies, is pursuing additional regulatory approvals for
VASCEPA in China, the European Union and the Middle East. For more
information about Amarin, visit www.amarincorp.com.
Availability of other Information about
Amarin
Investors and others should note that Amarin
communicates with its investors and the public using the company
website (www.amarincorp.com), the investor relations website
(investor.amarincorp.com), including but not limited to investor
presentations and investor FAQs, Securities and Exchange Commission
filings, press releases, public conference calls and webcasts. The
information that Amarin posts on these channels and websites could
be deemed to be material information. As a result, Amarin
encourages investors, the media, and others interested in Amarin to
review the information that is posted on these channels, including
the investor relations website, on a regular basis. This list of
channels may be updated from time to time on Amarin’s investor
relations website and may include social media channels. The
contents of Amarin’s website or these channels, or any other
website that may be accessed from its website or these channels,
shall not be deemed incorporated by reference in any filing under
the Securities Act of 1933.
Amarin Contact Information
Investor Inquiries:Elisabeth
SchwartzInvestor RelationsAmarin Corporation plcIn U.S.: +1 (908)
719-1315investor.relations@amarincorp.com
Lee M. SternSolebury TroutIn U.S.: +1 (646)
378-2992lstern@soleburytrout.com
Media Inquiries:Gwen
FisherCorporate CommunicationsAmarin Corporation plcIn U.S.: +1
(908) 325-0735pr@amarincorp.com
Amarin (NASDAQ:AMRN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Amarin (NASDAQ:AMRN)
Historical Stock Chart
From Sep 2023 to Sep 2024